发明公开
EP1453541A1 USE OF A GLUCOKINASE ACTIVATOR IN COMBINATION WITH A GLUCAGON ANTAGONIST FOR TREATING TYPE 2 DIABETES
审中-公开
使用结合胰高血糖素拮抗剂的组合的葡糖激酶活化剂2型糖尿病的治疗
- 专利标题： USE OF A GLUCOKINASE ACTIVATOR IN COMBINATION WITH A GLUCAGON ANTAGONIST FOR TREATING TYPE 2 DIABETES
- 专利标题（中）： 使用结合胰高血糖素拮抗剂的组合的葡糖激酶活化剂2型糖尿病的治疗
-
申请号： EP02781171.0申请日： 2002-12-03
-
公开(公告)号： EP1453541A1公开(公告)日： 2004-09-08
- 发明人: LAU, Jesper
- 申请人： NOVO NORDISK A/S
- 申请人地址： Novo Allé 2880 Bagsvaerd DK
- 专利权人： NOVO NORDISK A/S
- 当前专利权人： NOVO NORDISK A/S
- 当前专利权人地址： Novo Allé 2880 Bagsvaerd DK
- 优先权： DK200101789 20011203; US336876P 20011205; DK200101917 20011219; US342428P 20011220; DK200101925 20011220; US342355P 20011220; US386185P 20011221; EP02388015 20020219; US151683 20020517; DK200201006 20020627; DK200200999 20020627; US394145P 20020703; US394144P 20020703; US397809P 20020718; DK200201117 20020718
- 国际公布： WO2003047626 20030612
- 主分类号： A61K45/06
- IPC分类号： A61K45/06 ; A61P3/10 ; A61P3/06
摘要：
The invention relates to the use of a combination of a glucokinase activator and a glucagon antagonist for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity and inhibiting the activity of glucagon is beneficial, such as for management, treatment, control, or adjunct treatment of type 1 diabetes or type 2 diabetes.
信息查询
